Whether youre interested in Semaglutide, Retatrutide or other weight loss solutions, were here to help you achieve your goals
New hopes on 'SLU-PP-332' as an effective agent for weight loss with indirect kidney protection efficacy
The announcement comes a day after Eli Lilly and Novo Nordisk shares moved in opposite directions following their latest earnings reports, as Novo Nordisk warned of sales could decline this year, while Eli Lilly said its sales are expected to keep growing
Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease
Long gone are the days when weight loss was something you had to go at alone and thank goodness for that
Providers say theyre within FDA guidelines for the use of compounded drugs because theyre creating custom doses to meet each patients specific medical needs.) The FDA says some semaglutide products sold as compounds might be the salt forms, which differ from the base forms used in approved drugs
